Obatala Sciences

New Orleans, United States

Obatala Sciences is an assay and research tool development tissue-chip company that specializes in fat-chips.

$3.0M raised

Oct 2022

Series A

Biotechnology Health Care Life Science

Top Investors

Creative Destruction Lab Elevate Capital Benson Capital Partners Corridor Ventures The Hackett Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Obatala Sciences

How much funding has Obatala Sciences raised?

Obatala Sciences has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.

Who are Obatala Sciences's investors?

Obatala Sciences's investors include Creative Destruction Lab, Elevate Capital, Benson Capital Partners, Corridor Ventures, The Hackett Group.

Where is Obatala Sciences headquartered?

Obatala Sciences is headquartered in New Orleans, United States.

What does Obatala Sciences do?

Obatala Sciences is an assay and research tool development tissue-chip company that specializes in fat-chips.

What stage is Obatala Sciences at?

Obatala Sciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 13, 2022.

MLA

"Obatala Sciences — Funding & Investors." VCBacked, October 13, 2022, https://www.vcbacked.co/company/obatala-sciences. Accessed July 2, 2026.

APA

VCBacked. (2022). Obatala Sciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/obatala-sciences

Wikipedia (cite web)

{{cite web |title=Obatala Sciences — Funding & Investors |url=https://www.vcbacked.co/company/obatala-sciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 13, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K